Prasugrel may be the P2Y12 inhibitor of choice for use in combination with aspirin after PCI in patients with diabetes and ...

How bad will this year’s flu season be in the United States? At the moment, we have no answer to that important question.

How bad will this year’s flu season be in the United States? At the moment, we have no answer to that important question.

Recent media reports suggesting that comedian Kim Soo-yong, who suddenly lost consciousness during a YouTube filming, had ...

For patients with acute coronary syndrome, targeted vitamin D3 supplementation is associated with a reduced risk for follow-up myocardial infarction.

New study shows a longer course of dual antithrombotic therapy may not be necessary for some patients with atrial ...

A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...

The United States is facing a demographic shift as the population of older adults grows rapidly, with the proportion of ...

Researchers sought to determine the most appropriate P2Y12 inhibitor therapy in patients with acute coronary syndrome.

A inhibitors does not trigger MACEs when compared with TNF- α inhibitors in the 6 months following treatment initiation.

The phase 3 Librexia ACS trial evaluating the safety and efficacy of milvexian after a recent acute coronary syndrome has been discontinued.